Edition:
United Kingdom

Cellect Biotechnology Ltd (APOP.OQ)

APOP.OQ on NASDAQ Stock Exchange Capital Market

2.82USD
8:59pm GMT
Change (% chg)

$-0.08 (-2.76%)
Prev Close
$2.90
Open
$2.85
Day's High
$2.85
Day's Low
$2.82
Volume
301
Avg. Vol
3,585
52-wk High
$9.49
52-wk Low
$2.10

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Sep '18 0.00 -0.052
Jun '18 0.00 -0.046
Mar '18 0.00 -0.028
FY 2017 Dec '17 0.00 -0.028
Sep '17 0.00 -0.070
Jun '17 0.00 -0.042
Mar '17 0.00 -0.137
 
*Note: Units in Millions ofShekel
**Note: Units in Shekel

Consensus Estimates Analysis

No consensus analysis data available.

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 69.71 33.71
P/E High - Last 5 Yrs. -- 148.01 49.93
P/E Low - Last 5 Yrs. -- 47.79 24.27
Beta 2.07 1.08 0.90
Price to Sales (TTM) -- 49.51 6.28
Price to Book (MRQ) 12.06 10.16 5.27
Price to Tangible Book (MRQ) 12.39 13.82 6.79
Price to Cash Flow (TTM) -- 52.80 24.84
% Owned Institutions -- 3.75 1.69

Dividends

  Company industry sector
Dividend Yield -- 0.12 1.40
Dividend Yield - 5 Year Avg -- 0.09 1.42
Dividend 5 Year Growth Rate -- 0.79 4.83
Payout Ratio(TTM) -- 7.04 41.08

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 130.04 9.72
Sales (TTM) vs TTM 1 Yr. Ago -- 47.85 5.87
Sales - 5 Yr. Growth Rate -- 22.76 11.20
EPS (MRQ) vs Qtr. 1 Yr. Ago -8.79 75.87 47.26
EPS (TTM) vs TTM 1 Yr. Ago -60.47 -- --
EPS - 5 Yr. Growth Rate -- 12.03 10.82
Capital Spending - 5 Yr. Growth Rate 35.30 9.25 15.18

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 2.18 2.26
Current Ratio (MRQ) 8.17 3.43 3.08
LT Debt to Equity (MRQ) 0.00 18.73 11.38
Total Debt to Equity (MRQ) 0.00 31.43 16.13
Interest Coverage (TTM) -345.79 -43.27 29.51

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 56.29 53.78
Gross Margin - 5 Yr. Avg. -- 60.55 52.17
EBITD Margin (TTM) -- -- --
EBITD - 5 Yr. Avg -- -110.23 12.87
Operating Margin (TTM) -- -184.42 6.20
Operating Margin - 5 Yr. Avg. -- -126.68 8.31
Pre-Tax Margin (TTM) -- -175.20 7.17
Pre-Tax Margin - 5 Yr. Avg. -- -132.83 8.61
Net Profit Margin (TTM) -- -181.93 3.30
Net Profit Margin - 5 Yr. Avg. -- -137.23 4.88
Effective Tax Rate (TTM) -- 21.48 22.88
Effective Tax Rate - 5 Yr. Avg. -- 15.57 23.39

Efficiency

  Company industry sector
Revenue/Employee (TTM) -- 7,650,725 844,239,694
Net Income/Employee (TTM) -- 652,578 100,064,161
Receivable Turnover (TTM) -- 6.25 5.72
Inventory Turnover (TTM) -- 1.89 3.48
Asset Turnover (TTM) 0.00 0.32 0.93

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -128.02 6.45 11.08
Return on Assets - 5 Yr. Avg. -46.89 5.52 12.21
Return on Investment (TTM) -144.94 8.99 14.48
Return on Investment - 5 Yr. Avg. -72.71 6.85 15.88
Return on Equity (TTM) -182.75 10.13 15.99
Return on Equity - 5 Yr. Avg. -76.69 8.39 17.00
  1 Year 3 Year 5 Year
Sales % -- -- --
EPS (TTM) % -23.06 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Cellect Biotechnology Ltd

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.